1,350,000 ORDINARY SHARES VIRAX BIOLABS GROUP LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • July 26th, 2022 • Virax Biolabs Group LTD • In vitro & in vivo diagnostic substances • New York
The undersigned, Virax Biolabs Group Limited, a company incorporated under the laws of the Cayman Islands (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of Virax Biolabs Group Limited, the “Company”), hereby confirms its agreement (this “Agreement ”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Boustead Securities, LLC is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.
